UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
IDEAYA Biosciences
IDYA
$3.17B
| $5.34M | ﹤0.01% |
143,285
-31,866
| -18% | -$975K |
2023 Q3
11 quarters
|
|
1552
FMC
FMC
$717M
| $5.34M | ﹤0.01% |
464,182
-23,201
| -5% | -$324K |
2013 Q2
52 quarters
|
|
1553
Magnolia Oil & Gas
MGY
$7.12B
| $5.33M | ﹤0.01% |
208,440
+1,627
| +0.8% | +$46.5K |
2019 Q2
28 quarters
|
|
1554
Crane NXT
CXT
$3.28B
| $5.33M | ﹤0.01% |
104,186
-374
| -0.4% | -$16K |
2013 Q2
52 quarters
|
|
1555
Bain Capital GSS Investment Corp
BCSS
$596M
| $5.32M | ﹤0.01% |
518,210
-28,041
| -5% | -$285K |
2026 Q1
1 quarter
|
|
1556
Dynex Capital
DX
$2.7B
| $5.31M | ﹤0.01% |
404,988
+60,731
| +18% | +$799K |
2025 Q4
2 quarters
|
|
1557
Protolabs
PRLB
$2.07B
| $5.3M | ﹤0.01% |
65,044
-697
| -1% | -$49K |
2013 Q2
52 quarters
|
|
1558
Red Rock Resorts
RRR
$2.97B
| $5.3M | ﹤0.01% |
81,387
-5,286
| -6% | -$301K |
2017 Q2
36 quarters
|
|
1559
Intellia Therapeutics
NTLA
$1.58B
| $5.29M | ﹤0.01% |
312,809
+28,851
| +10% | +$404K |
2019 Q2
28 quarters
|
|
1560
Bunge Global
BG
$19.6B
| $5.26M | ﹤0.01% |
49,288
-1,109,865
| -96% | -$136M |
2013 Q2
52 quarters
|
|
1561
First Trust Dow 30 Equal Weight ETF
EDOW
$325M
| $5.25M | ﹤0.01% |
119,168
| – | – |
2026 Q1
1 quarter
|
|
1562
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$8.98B
| $5.23M | ﹤0.01% |
128,722
| – | – |
2026 Q1
1 quarter
|
|
1563
NeoGenomics
NEO
$2.14B
| $5.22M | ﹤0.01% |
357,728
-2,185
| -0.6% | -$21.1K |
2023 Q1
13 quarters
|
|
1564
Perpetua Resources
PPTA
$2.08B
| $5.21M | ﹤0.01% |
251,152
+244,137
| +3,480% | +$6.62M |
2025 Q4
2 quarters
|
|
1565
Relay Therapeutics
RLAY
$3.97B
| $5.21M | ﹤0.01% |
278,327
+67,859
| +32% | +$985K |
2020 Q3
23 quarters
|
|
1566
Stewart Information Services
STC
$1.31B
| $5.2M | ﹤0.01% |
78,828
+25
| +0% | +$1.67K |
2013 Q2
52 quarters
|
|
1567
Helmerich & Payne
HP
$3.98B
| $5.19M | ﹤0.01% |
158,621
-82,303
| -34% | -$3.08M |
2013 Q2
52 quarters
|
|
1568
RXO
RXO
$4.73B
| $5.18M | ﹤0.01% |
187,901
-57,702
| -23% | -$1.27M |
2022 Q4
14 quarters
|
|
1569
Royal Bank of Canada
RY
$280B
| $5.17M | ﹤0.01% |
24,997
| – | – |
2024 Q2
8 quarters
|
|
1570
Amentum Holdings
AMTM
$5.4B
| $5.16M | ﹤0.01% |
249,725
+1,768
| +0.7% | +$42.8K |
2024 Q3
7 quarters
|
|
1571
JPMorgan International Value ETF
JIVE
$4.46B
| $5.1M | ﹤0.01% |
55,493
| – | – |
2026 Q1
1 quarter
|
|
1572
Core Natural Resources Inc
CNR
$4.39B
| $5.09M | ﹤0.01% |
63,563
+843
| +1% | +$74.7K |
2021 Q4
18 quarters
|
|
1573
TE Connectivity
TEL
$61.9B
| $5.08M | ﹤0.01% |
25,188
-2,229,956
| -99% | -$475M |
2016 Q4
38 quarters
|
|
1574
Aehr Test Systems
AEHR
$1.85B
| $5.07M | ﹤0.01% |
52,815
+18,434
| +54% | +$1.68M |
2025 Q4
2 quarters
|
|
1575
CoreCivic
CXW
$2.95B
| $5.07M | ﹤0.01% |
166,968
+5,982
| +4% | +$136K |
2013 Q2
52 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.